Tyr(1)-ψ[(Z)CF=CH]-Gly(2) Fluorinated Peptidomimetic Improves Distribution and Metabolism Properties of Leu-Enkephalin

by Altman, Ryan A., Sharma, Krishna K., Rajewski, Lian G., Toren, Paul C., Baltezor, Michael J., Pal, Mohan, Karad, Somnath N.
Published in ACS Chem Neurosci (2018)

Preclinical Pharmacokinetics of Fosciclopirox, a Novel Treatment of Urothelial Cancers, in Rats and Dogs

by Weir, Scott J., Wood, Robyn, Schorno, Karl, Brinker, Amanda E., Ramamoorthy, Prabhu, Heppert, Kathy, Rajewski, Lian, Tanol, Mehmet, Ham, Tammy, McKenna, Michael J., McCulloch, William, Dalton, Michael, Reed, Gregory A., Jensen, Roy A., Baltezor, Michael J., Anant, Shrikant, Taylor, John A.
Published in J Pharmacol Exp Ther (2019)

Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex

by Weir, Scott J., Dandawate, Prasad, Standing, David, Bhattacharyya, Sangita, Ramamoorthy, Prabhu, Rangarajan, Parthasarathy, Wood, Robyn, Brinker, Amanda E., Woolbright, Benjamin L., Tanol, Mehmet, Ham, Tammy, McCulloch, William, Dalton, Michael, Reed, Gregory A., Baltezor, Michael J., Jensen, Roy A., Taylor, John A., Anant, Shrikant
Published in Cell Death Dis (2021)

A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax(®)) in patients with peritoneal malignancies

by Williamson, Stephen K., Johnson, Gary A., Maulhardt, Holly A., Moore, Kathleen M., McMeekin, D. S., Schulz, Thomas K., Reed, Gregory A., Roby, Katherine F., Mackay, Christine B., Smith, Holly J., Weir, Scott J., Wick, Jo A., Markman, Maurie, diZerega, Gere S., Baltezor, Michael J., Espinosa, Jahna, Decedue, Charles J.
Published in Cancer Chemother Pharmacol (2015)